Showing results (1481-1490 of 1,523) with videos related to
Sort By:
Pageof 153
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2026
LAMPAD:An Integrated ctDNA-Based Model for Predicting Potential Cure in Resected NSCLC PatientsJia-Tao Zhang, Ke-Zhong Chen, Xuan Gao, et al.Clinical Lung Cancer|October 25, 2023
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)Jia-Tao Zhang, Song Dong, Wei-Quan Gu, et al.Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) studyJian Zeng, Wei-Min Mao, Qi-Xun Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III TrialWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.Cell Reports. Medicine|June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.Cancer Cell|October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patientsYi Pan, Jia-Tao Zhang, Xuan Gao, et al.Cell Reports|August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLCYang-Si Li, Wen-Pu Lai, Kai Yin, et al.Nature Medicine|July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trialSi-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.Molecular Psychiatry|June 6, 2022
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to actionKai Yuan, Yong-Bo Zheng, Yi-Jie Wang, et al.Pageof 153